Dr. Daniel Shank said family medicine serves as the front line of patient health, requiring doctors to know about all aspects ...

Gun violence may hit a historic low this year and trend is coming into focus through those closest to it: the emergency ...

Bristol Myers Squibb BMY obtained the European Commission’s (“EC”) approval for a label expansion of Breyanzi (lisocabtagene ...

Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated ...

Multiple pre-exposure (PrEP) and postexposure (PEP) treatments are now available to prevent HIV infection. An updated ...

Ultimately, investigators found a significant reduction in ischemic stroke risk with asundexian compared to placebo, both in combination with antiplatelet therapy. Additionally, participants had no ...

Coronary heart disease and comorbid chronic diseases, including but not limited to hypertension, diabetes, stroke, chronic ...

A fire that tore through a vacant home on Aylmer Avenue early Friday was intentionally set, Windsor Fire and Rescue Services ...

(TSXV: AVCR) (the "Company " or “Avricore ”) is pleased to announce HealthTab™ is being deployed in a new pilot launched by Barts Health NHS Trust, in collaboration with UCL Partners and the British ...

Esperion Therapeutics gains strong outlook as Piper Sandler cites rapid sales growth for cholesterol drugs Nexletol/Nexlizet.

Asundexian is designed to reduce thrombus formation without increasing bleeding risk by selectively inhibiting FXIa.

Once-daily asundexian 50 mg, on top of antiplatelet therapy, reduced risk for recurrent ischemic stroke after a ...